NCT06573424 2025-05-01
Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Completed
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Peking University